Detection of OXA-48 Gene in Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae from Urine Samples

References

• Noyal MJ, Menezes GA, Harish BN, Sujatha S, Parija SC. Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria. Indian J Med Res. 2009;129:707–712.19692754
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L. Strategies for identification of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2013;68(3):487–489. doi:10.1093/jac/dks42623104494
   PubMed Web of Science ®Google Scholar
• Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother. 2010;65(6):1119–1125. doi:10.1093/jac/dkq10820378670
   PubMed Web of Science ®Google Scholar
• Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597–602. doi:10.1016/S1473-3099(10)70143-220705517
   PubMed Web of Science ®Google Scholar
• Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20:440–458. doi:10.1128/CMR.00001-0717630334
   PubMed Web of Science ®Google Scholar
• Evans BA, Amyes SG. OXA -Lactamases. Clin Microbiol Rev. 2014;27(2):241–263. doi:10.1128/CMR.00117-1324696435
   PubMed Web of Science ®Google Scholar
• Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48(1):15–22. doi:10.1128/AAC.48.1.15-22.200414693513
   PubMed Web of Science ®Google Scholar
• Poirel L, Carbonnelle E, Bernabeu S, Gutmann L, Rotimi V, Nordmann P. Importation of OXA-48-producing Klebsiella pneumoniae from Kuwait. J Antimicrob Chemother. 2012;67(8):2051–2052. doi:10.1093/jac/dks16722577102
   PubMed Web of Science ®Google Scholar
• Bakthavatchalam YD, Anandan S, Veeraraghavan B. Laboratory detection and clinical implication of oxacillinase-48 like carbapenemase: the hidden threat. J Glob Infect Dis. 2016;8:41–50. doi:10.4103/0974-777X.17614927013843
   PubMed Web of Science ®Google Scholar
• Oueslati S, Retailleau P, Marchini L, et al. Biochemical and structural characterization of OXA-405, an OXA-48 variant with extended-spectrum beta-lactamase activity. Microorganisms. 2019;8:24.
   Web of Science ®Google Scholar
• Marshall BM, Levy SB. Food animals and antimicrobials: inputs on human health. Clin Microb Rev. 2011;24(4):718–733. doi:10.1128/CMR.00002-11
   PubMed Web of Science ®Google Scholar
• Caruso G, Giammanco A, Cardamone C, et al. Extraintestinal fluoroquinolone resistant Escherichia coli strains isolated from meat. Bio Med Res Int. 2018;8714975:7.
   Google Scholar
• Fasciana T, Giordano G, DI CARLO P, et al. Virulence factors and antimicrobial resistance of Escherichia coli ST131 in community-onset healthcare-associated infections in Sicily, Italy. Pharmacology online. 2017;1:12–21.
   Google Scholar
• Fasciana T, Gentile B, Aquilina M, et al. Co-existence of virulence factors and antibiotic resistance in new Klebsiella pneumoniae clones emerging in south of Italy. BMC Infect Dis. 2019;19(1):928. doi:10.1186/s12879-019-4565-331684890
   PubMed Web of Science ®Google Scholar
• Karn S, Pant ND, Neupane S, Khatiwada S, Basnyat S, Shrestha B. Prevalence of carbapenem resistant bacterial strains isolated from different clinical samples: study from a tertiary care hospital in Kathmandu, Nepal. JBS. 2016;3(1):11–15.
   Google Scholar
• Dhungana K, Awal BK, Dhungel B, Sharma S, Banjara MR, Rijal KR. Detection of Klebsiella pneumoniae carbapenemase (KPC) and metallo betalactamae (MBL) producing Gram negative bacteria isolated from different clinical samples in a transplant center, Kathmandu, Nepal. ASMI. 2019;2(12):60–69.
   Google Scholar
• Pokharel K, Dawadi BR, Bhatt CP, Gupte S, Jha B. Resistance pattern of carbapenem on Enterobacteriaceae. JNMA J Nepal Med Assoc. 2018;56(214):931–935. doi:10.31729/jnma.400631065137
   PubMed Web of Science ®Google Scholar
• Rijal BP, Sherchand JP, Pokharel BM, et al. Carabapenem-resistant E. coli among the hospitilized patients with UTI in a tertiary care center of Nepal. PGMJ Nat ACa Med Sci. 2014;14(1):29–33.
   Google Scholar
• Sherchan JB, Tada T, Shrestha S, et al. Emergence of clinical isolates of highly carbapenem-resistant Klebsiella pneumoniae co-harboring blaNDM-5 and blaOXA-181 or −232 in Nepal. Int J Infect Dis. 2020;92:247–252. doi:10.1016/j.ijid.2020.01.04031982619
   PubMed Web of Science ®Google Scholar
• Adhikari S, Khadka S, Rana JC, et al. Prevalence of β-lactamase producing carbapenem-resistant Enterobacteriaceae among the patients attending Bharatpur Hospital. Biosci Dis. 2019;10(2):64–71.
   Google Scholar
• Forbes BA, Daniel SF, Weissfelt SA. Bailey and Scott’s Diagnostic Microbiology. St Louis, MO: Mosby; 2007.
   Google Scholar
• Isenberg HD. Clinical Microbiology Procedures Handbook. 2nd ed. Washington, DC: ASM Press; 2004.
   Google Scholar
• Versalovic J, Carroll K, Funke G, Jorgensen JH, Landry ML, Warnock DW, Eds. Manual of Clinical Microbiology. 10th ed. American Society of Microbiology; 2011.
   Google Scholar
• Collee JG, Mackie TJ, McCartney JE. Mackie and McCartney Practical Medical Microbiology. 14th ed. New York: Churchill Livingstone; 1996:131–149.
   Google Scholar
• Tille P. Bailey and Scott’s Diagnostic Microbiology. 13th ed. Mosby; 2014:323–324.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. Wayne, PA: Informational supplement M100-S28; 2018.
   Google Scholar
• Sambrook J, Russell D. Molecular Cloning: A Laboratory Manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2001.
   Google Scholar
• Dallenne C, Da Costa A, Decre D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65(3):490–495. doi:10.1093/jac/dkp49820071363
   PubMed Web of Science ®Google Scholar
• Ganesh R, Shrestha D, Bhattachan B, Rai G. Epidemiology of urinary tract infection and antimicrobial resistance in a pediatric hospital in Nepal. BMC Infect Dis. 2019;19(1):420. doi:10.1186/s12879-019-3997-031088380
   PubMed Web of Science ®Google Scholar
• Pradhan B, Pradhan S. Prevalence of urinary tract infection and antibiotic susceptibility pattern to urinary pathogens in Kathmandu Medical College and Teaching Hospital, Duwakot. BJHS. 2017;2(1):134–137.
   Google Scholar
• Thakur P, Ghimire P, Rijal KR, Singh GK. Antimicrobial resistance pattern of Esherichia coli isolated from urine samples in patients visiting tertiary health care centre in Eastern Nepal. Sunsari Tech Coll J. 2013;1(1):22–26. doi:10.3126/stcj.v1i1.8657
   Google Scholar
• Shakya P, Shrestha D, Maharjan E, Sharma VK, Paudyal R. ESBL production among E. coli and Klebsiella spp. causing urinary tract infection: a hospital based study. Open Microbiol J. 2017;11(1):23–30. doi:10.2174/187428580171101002328553414
   PubMedGoogle Scholar
• Guragin N, Pradhan A, Dhungel B, Banjara MR, Rijal KR, Ghimire P. Extended spectrum B-lactamase producing Gram negative bacterial isolates from urine of patients visiting Everest Hospital, Kathmandu, Nepal. TUJM. 2019;6(1):26–31.
   Google Scholar
• Shrestha LB, Baral R, Poudel P, Khanal B. Clinical, etiological and antimicrobial susceptibility profile of pediatric urinary tract infections in a tertiary care hospital of Nepal. BMC Pediatr. 2019;19(1):36. doi:10.1186/s12887-019-1410-130696410
   PubMed Web of Science ®Google Scholar
• Raut S, Rijal KR, Khatiwada S, et al. Trend and characteristics of Acinetobacter baumannii infections in patients attending Universal College of Medical Sciences, Bhairahawa, Western Nepal: a longitudinal study of 2018. Infect Drug Resist. 2020;13:1631–1641. doi:10.2147/IDR.S25785132606814
   PubMed Web of Science ®Google Scholar
• Kaur N, Sharma S, Malhotra S, Madan P, Hans C. Urinary tract infection: aetiology and antimicrobial resistance pattern in infants from a tertiary care hospital in northern India. J Clin Diagn Res. 2014;8:1–3.
   Google Scholar
• Seifu WD, Gebissa AD. Prevalence and antibiotic susceptibility of uropathogens from cases of urinary tract infections (UTI) in Shashemene Referral Hospital, Ethiopia. BMC Infect Dis. 2018;18(1):30. doi:10.1186/s12879-017-2911-x29320984
   PubMed Web of Science ®Google Scholar
• Majeed HT, Aljanaby AAJ. Antibiotic susceptibility patterns and prevalence of some extended spectrum beta-lactamases genes in Gram-negative bacteria isolated from patients infected with urinary tract infections in Al-Najaf City, Iraq. Avicenna J Med Biotechnol. 2019;11:192–201.31057723
   PubMedGoogle Scholar
• Ponce-de-Leon A, Rodriguez-Noriega E, Morfin-Otero R, et al. Antimicrobial susceptibility of Gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: results from the study for monitoring Antimicrobial Resistance Trends (SMART). PLoS One. 2018;13(6):e0198621. doi:10.1371/journal.pone.019862129927958
   PubMed Web of Science ®Google Scholar
• Kot B, Wicha J, Zak-Palawska Z. Susceptibility of Escherichia coli strains isolated from persons with urinary tract infections in 2007–2008 to antimicrobial agents. Przegl Epidemiol. 2010;64:307–312.20731243
   PubMedGoogle Scholar
• McLellan LK, Hunstad DA. Urinary tract infection: pathogenesis and outlook. Trends Mol Med. 2016;22(11):946–957. doi:10.1016/j.molmed.2016.09.00327692880
   PubMed Web of Science ®Google Scholar
• Kayastha K, Dhungel B, Karki S, et al. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in pediatric patients visiting International Friendship Children’s Hospital, Kathmandu, Nepal. Infect Dis. 2020;13:1–7.
   Google Scholar
• Gautam R, Chapagain M, Acharya A, et al. Antimicrobial susceptibility patterns of Escherichia coli from various clinical sources. JCMC. 2013;3(1):14–17. doi:10.3126/jcmc.v3i1.8459
   Google Scholar
• Tamang K, Shrestha P, Koirala A, Khadka J, Gautam N, Rijal KR. Prevalence of bacterial uropathogens among diabetic patients attending Padma Nursing Hospital of Western Nepal. HiJOST. 2017;1:15–19.
   Google Scholar
• Rawat D, Nair D. Extended-spectrum beta-lactamases in Gram negative bacteria. J Glob Infect Dis. 2010;2:263–274. doi:10.4103/0974-777X.6853120927289
   PubMedGoogle Scholar
• Pokharel S, Raut S, Adhikari B. Tackling antimicrobial resistance in low-income and middle-income countries. BMJ Glob Health. 2019;4(6):e002104. doi:10.1136/bmjgh-2019-002104
   PubMed Web of Science ®Google Scholar
• Mishra SK, Awal BK, Kattel HP, et al. Drug resistant bacteria are growing menace in a University Hospital in Nepal. Amer J Epidem Infec Dis. 2014;2:19–23.
   Google Scholar
• Tankhiwale SS, Jalgaonkar SV, Ahamad S, Hassani U. Evaluation of extended spectrum beta-lactamases in urinary isolates. Indian J Med Res. 2004;12:1005–1008.
   Google Scholar
• Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital, Aligarh, India. Ann Clin Microbiol Antimicrob. 2007;6:4. doi:10.1186/1476-0711-6-417378940
   PubMedGoogle Scholar
• Hasan AS, Nair D, Kaur J, Baweja G, Deb M, Aggarwal P. Resistance patterns of urinary isolates in a tertiary Indian Hospital. J Ayub Med Coll Abbottabad. 2007;19:39–41.17867478
   PubMedGoogle Scholar
• Neupane S, Pant ND, Khatiwada S, Chaudhary R, Banjara MR. Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal. Antimicrob Resist Infect Control. 2016;5:5.26885364
   PubMed Web of Science ®Google Scholar
• Nepal K, Pant ND, Neupane B, et al. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal. Ann Clin Microbiol Antimicrob. 2017;16(1):62. doi:10.1186/s12941-017-0236-728927454
   PubMed Web of Science ®Google Scholar
• Parajuli NP, Maharjan P, Parajuli H, et al. High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal. Antimicrob Resist Infect Control. 2017;6(1):9. doi:10.1186/s13756-016-0168-628096977
   PubMed Web of Science ®Google Scholar
• Upadhyay A, Parajuli P. Extended spectrum β-lactamases (ESBL)-producing Klebsiella species isolated at National Medical College and Teaching Hospital Nepal. Asian J Pharma Clin Res. 2013;1:161–164.
   Google Scholar
• Raut S, Adhikari B. ESBL and their identification in peripheral laboratories of Nepal. Nepal Med Coll J. 2015;17(3–4):176–181.
   Google Scholar
• Shrestha S, Amatya R, Dutta R. Prevalence of extended spectrum beta lactamase (ESBL) production in Gram negative isolates from pyogenic infection in tertiary care hospital of eastern Nepal. Nepal Med Coll J. 2011;13(3):186–189.22808812
   PubMedGoogle Scholar
• Kulkarni DM, Badrapurkar SA, Nilekar SL, More SR. Prevalence of extended spectrum beta-lactamase producing E. coli and Klebsiella species in urinary isolates. J Dental Med Sci. 2016;15:26–29.
   Google Scholar
• Nikaido H. Multidrug resistance in bacteria. Annu Rev Biochem. 2009;78(1):119–146. doi:10.1146/annurev.biochem.78.082907.14592319231985
   PubMed Web of Science ®Google Scholar
• Livermore DM. Has the era of untreatable infections arrived? J Antimicrob Chemother. 2009;64(Supplement 1):29–36. doi:10.1093/jac/dkp255
   Web of Science ®Google Scholar
• Bora A, Sanjana R, Jha BK, Mahaseth SN, Pokharel K. Incidence of metallo-beta-lactamase producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in central Nepal. BMC Res Notes. 2014;7(1):557. doi:10.1186/1756-0500-7-55725146590
   PubMedGoogle Scholar
• Datta P, Gupta V, Garg S, Chander J. Phenotypic method for differentiation of carbapenemases in Enterobacteriaceae: study from north India. Indian J Pathol Microbiol. 2012;55(3):357–360. doi:10.4103/0377-4929.10174423032831
   PubMed Web of Science ®Google Scholar
• Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. Carbapenems: past, present, and future. Antimicrob Agents Chemother. 2011;55(11):4943–4960. doi:10.1128/AAC.00296-1121859938
   PubMed Web of Science ®Google Scholar
• Mathias AOA, Oberoi A, John M, Alexander V. Prevalence of carbapenemase-producing organisms in a tertiary care hospital in Ludhiana. CHRISMED J Health Res. 2016;3(4):263–267. doi:10.4103/2348-3334.190574
   Google Scholar
• Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18(5):263–272. doi:10.1016/j.molmed.2012.03.00322480775
   PubMed Web of Science ®Google Scholar
• Pfeifer Y, Schlatterer K, Engelmann E, et al. Emergence of OXA-48-type carbapenemase-producing Enterobacteriaceae in German hospitals. Antimicrob Agents Chemother. 2012;56(4):2125–2128. doi:10.1128/AAC.05315-1122290940
   PubMed Web of Science ®Google Scholar
• Aqel AA, Giakkoupi P, Alzoubi H, Masalha I, Ellington MJ, Vatopoulos A. Detection of OXA-48-like and NDM carbapenemases producing Klebsiella pneumoniae in Jordan: a pilot study. J Infect Public Health. 2017;10(2):150–155. doi:10.1016/j.jiph.2016.02.00226993738
   PubMed Web of Science ®Google Scholar
• Huang S-R, Liu M-F, Lin C-F, Shi Z-Y. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections. J Microbiol Immunol Infect. 2014;47(3):187–196. doi:10.1016/j.jmii.2012.08.02923200553
   PubMedGoogle Scholar
• Potron A, Kalpoe J, Poirel L, Nordmann P. European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone. Clin Microbiol Infect. 2011;17(12):24–26. doi:10.1111/j.1469-0691.2011.03669.x
   Web of Science ®Google Scholar
• Gottig S, Gruber TM, Stecher B, Wichelhaus TA, Kempf VA. In vivo horizontal gene transfer of the carbapenemase OXA-48 during a nosocomial outbreak. Clin Infect Dis. 2015;60(12):1808–1815. doi:10.1093/cid/civ19125759432
   PubMed Web of Science ®Google Scholar
• Fursova NK, Astashkin EI, Knyazeva AI, et al. The spread of bla OXA-48 and bla OXA-244 carbapenemase genes among Klebsiella pneumoniae, Proteus mirabilis and Enterobacter spp. isolated in Moscow, Russia. Ann Clin Microbiol Antimicrob. 2015;14:46. doi:10.1186/s12941-015-0108-y26526183
   PubMed Web of Science ®Google Scholar
• Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012;67(7):1597–1606. doi:10.1093/jac/dks12122499996
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Fact sheet antimicrobial resistance. 2018 Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed 315, 2020.
   Google Scholar
• Pokharel S, Adhikari B. Antimicrobial resistance and over the counter use of drugs in Nepal. J Global Health. 2020;10(1):1. doi:10.7189/jogh.10.010360
   Web of Science ®Google Scholar
• Raut S, Adhikari B. Ceftazidime-avibactam in ceftazidime-resistant infections. Lancet Infect Dis. 2016;16(9):997. doi:10.1016/S1473-3099(16)30194-3
   Web of Science ®Google Scholar
• Raut S, Adhikari B. Global leadership against antimicrobial resistance ought to include developing countries. Lancet Infect Dis. 2016;16(7):775. doi:10.1016/S1473-3099(16)30078-0
   Web of Science ®Google Scholar
• Storr J, Twyman A, Zingg W, et al. Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. Antimicrob Resist Infect Control. 2017;6(1):6. doi:10.1186/s13756-016-0149-928078082
   PubMed Web of Science ®Google Scholar
• Bamford R, Smith A, Metz J, et al. Investigating the physiology of viable but non-culturable bacteria by microfluidics and time-lapse microscopy. BMC Biol. 2017;15(1):121. doi:10.1186/s12915-017-0465-429262826
   PubMed Web of Science ®Google Scholar
• Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. Bacterial persistence as a phenotypic switch. Science. 2004;305(5690):1622–1625. doi:10.1126/science.109939015308767
   PubMed Web of Science ®Google Scholar